Re: Biogen looks to FDA for approval of early Alzheimers drug.
in response to
by
posted on
Oct 22, 2019 10:21AM
There you go..."In essence, Sandrock said, the futility analysis had happened too soon."
Perhaps if BOM went for a longer stretch, it would have netted better Top-Line results.
Koo